Fifty Years of Research on Schizophrenia: The Ascendance of the Glutamatergic Synapse.
作者信息
Coyle Joseph T, Ruzicka W Brad, Balu Darrick T
机构信息
Harvard Medical School and McLean Hospital, Belmont, Mass.
出版信息
Am J Psychiatry. 2020 Dec 1;177(12):1119-1128. doi: 10.1176/appi.ajp.2020.20101481.
Abstract
摘要
相似文献
1
Fifty Years of Research on Schizophrenia: The Ascendance of the Glutamatergic Synapse.
Am J Psychiatry. 2020 Dec 1;177(12):1119-1128. doi: 10.1176/appi.ajp.2020.20101481.
2
Glutamatergic animal models of schizophrenia.
Curr Pharm Des. 2012;18(12):1593-604. doi: 10.2174/138161212799958576.
3
Celebrating twenty years of schizophrenia research.
Schizophr Res. 2008 Mar;100(1-3):1-3. doi: 10.1016/j.schres.2008.01.021. Epub 2008 Feb 13.
4
Significance of dysfunctional glutamatergic transmission for the development of psychotic symptoms.
Pol J Pharmacol. 2003 Mar-Apr;55(2):133-54.
5
Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia.
Ann N Y Acad Sci. 2003 Nov;1003:75-93. doi: 10.1196/annals.1300.005.
6
Editorial: New treatment strategies in schizophrenia beyond dopamine: glutamatergic neurotransmission and more.
Curr Pharm Biotechnol. 2012 Jun;13(8):1474-5. doi: 10.2174/138920112800784871.
7
The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.
Am J Psychiatry. 2001 Sep;158(9):1367-77. doi: 10.1176/appi.ajp.158.9.1367.
8
Novel therapies for schizophrenia: understanding the glutamatergic synapse and potential targets for altering N-methyl-D-aspartate neurotransmission.
Recent Pat CNS Drug Discov. 2009 Nov;4(3):220-38. doi: 10.2174/157488909789104857.
9
Schizophrenia and glutamatergic transmission.
Crit Rev Neurobiol. 1998;12(1-2):21-36. doi: 10.1615/critrevneurobiol.v12.i1-2.20.
10
Role of central glutamatergic neurotransmission in the pathogenesis of psychiatric and behavioral disorders.
Drug News Perspect. 2005 Nov;18(9):561-6. doi: 10.1358/dnp.2005.18.9.953668.
引用本文的文献
1
Prenatal Exposure to Lipopolysaccharide or Valproate Leads to Abnormal Accumulation of the NMDA Receptor Agonist D-Aspartate in the Adolescent Rat Brain.
J Neurochem. 2025 Jun;169(6):e70095. doi: 10.1111/jnc.70095.
2
Future Perspectives of NMDAR in CNS Disorders.
Molecules. 2025 Feb 14;30(4):877. doi: 10.3390/molecules30040877.
3
A Critical Reappraisal of Haloperidol for Delirium Management in the Intensive Care Unit: Perspective from Psychiatry.
J Clin Med. 2025 Jan 11;14(2):438. doi: 10.3390/jcm14020438.
4
Early postnatal NMDA receptor ablation in cortical interneurons impairs affective state discrimination and social functioning.
Neuropsychopharmacology. 2025 Jun;50(7):1119-1129. doi: 10.1038/s41386-025-02051-0. Epub 2025 Jan 20.
5
Variations of blood D-serine and D-aspartate homeostasis track psychosis stages.
Schizophrenia (Heidelb). 2024 Dec 19;10(1):115. doi: 10.1038/s41537-024-00537-2.
6
Mismatch Negativity (MMN) as a Pharmacodynamic/Response Biomarker for NMDA Receptor and Excitatory/Inhibitory Imbalance-Targeted Treatments in Schizophrenia.
Adv Neurobiol. 2024;40:411-451. doi: 10.1007/978-3-031-69491-2_15.
7
Dysfunction of the NMDA Receptor in the Pathophysiology of Schizophrenia and/or the Pathomechanisms of Treatment-Resistant Schizophrenia.
Biomolecules. 2024 Sep 6;14(9):1128. doi: 10.3390/biom14091128.
8
An increased copy number of glycine decarboxylase (GLDC) associated with psychosis reduces extracellular glycine and impairs NMDA receptor function.
Mol Psychiatry. 2025 Mar;30(3):927-942. doi: 10.1038/s41380-024-02711-5. Epub 2024 Aug 30.
9
Decreased free D-aspartate levels in the blood serum of patients with schizophrenia.
Front Psychiatry. 2024 Jul 10;15:1408175. doi: 10.3389/fpsyt.2024.1408175. eCollection 2024.
10
Impact of Serine Racemase Deletion on Nicotine Discrimination.
Nicotine Tob Res. 2024 Nov 22;26(12):1744-1748. doi: 10.1093/ntr/ntae156.
本文引用的文献
1
Consequences of NMDA receptor deficiency can be rescued in the adult brain.
Mol Psychiatry. 2021 Jul;26(7):2929-2942. doi: 10.1038/s41380-020-00859-4. Epub 2020 Aug 17.
2
The polygenic architecture of schizophrenia - rethinking pathogenesis and nosology.
Nat Rev Neurol. 2020 Jul;16(7):366-379. doi: 10.1038/s41582-020-0364-0. Epub 2020 Jun 11.
3
Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis.
Lancet Psychiatry. 2020 May;7(5):399-410. doi: 10.1016/S2215-0366(20)30057-2. Epub 2020 Mar 24.
4
Epigenetic memory in development and disease: Unraveling the mechanism.
Biochim Biophys Acta Rev Cancer. 2020 Apr;1873(2):188349. doi: 10.1016/j.bbcan.2020.188349. Epub 2020 Jan 23.
5
Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene.
Biol Psychiatry. 2019 Oct 1;86(7):523-535. doi: 10.1016/j.biopsych.2019.04.031. Epub 2019 May 9.
6
Neuron-specific signatures in the chromosomal connectome associated with schizophrenia risk.
Science. 2018 Dec 14;362(6420). doi: 10.1126/science.aat4311.
7
Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: Systematic review and meta-analysis.
Drug Alcohol Depend. 2018 Oct 1;191:234-258. doi: 10.1016/j.drugalcdep.2018.07.011. Epub 2018 Aug 22.
8
Alterations in cortical interneurons and cognitive function in schizophrenia.
Neurobiol Dis. 2019 Nov;131:104208. doi: 10.1016/j.nbd.2018.06.020. Epub 2018 Jun 22.
9
Glutamatergic Deficits in Schizophrenia - Biomarkers and Pharmacological Interventions within the Ketamine Model.
Curr Pharm Biotechnol. 2018;19(4):293-307. doi: 10.2174/1389201019666180620112528.
10
Astrocytes in primary cultures express serine racemase, synthesize d-serine and acquire A1 reactive astrocyte features.
Biochem Pharmacol. 2018 May;151:245-251. doi: 10.1016/j.bcp.2017.12.023. Epub 2018 Jan 3.
Zotero 插件